Berkshire Hathaway Increases Alphabet Stake by 224 and Takes 26 Billion Position in Delta Air Lines Middle East Conflict Poses Challenges to Gulfs AI Hub Ambitions Reddit Shares Slide Nearly 6 as Meta Launches Competing Forum App Amazons Dominance in Western ECommerce Why Rivals Have Failed to Close the Gap FORT Robotics Acquires Mapless AI to Strengthen Trust Platform with Remote Supervision and Active Safety Capabilities Lloyds Banking Groups Potential PhaseOut of Halifax Brand Sparks Concern in Yorkshire Town Adamas Trust ADAML Q1 2026 Earnings Preferred Stock Delivers Strong EPS Beat on FixedtoFloating Rate Structure LAZ Q1 2026 Earnings EPS Falls Short of Estimates as Stock Inches Higher OPTT Q1 2026 Earnings EPS Misses Estimates as Stock Rises Over 7 BBAR Q4 2025 Earnings Earnings Beat Estimates Despite Stock Decline Atomera Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Surge Nasdaq Inc NDAQ Q1 2026 Earnings EPS Surpasses Estimates as Stock Ticks Higher Universal Technical Institute UTI Consolidates Near 3991 With Minimal Price Movement Almonty Industries ALM Holds Near Support as Price Declines Fractionally Neumora Therapeutics NMRA Edges Lower as Stock Tests Key Support at 175 Design Therapeutics DSGN Declines 2 as Shares Test Key Support Levels GCL Global Holdings Warrants GCLWW Rally 2187 Key Levels and Potential Outlook Summertime Strain Rising Electricity Prices and Heat Wave Could Drive Utility Bills Higher BANX Q4 2022 Earnings EPS Slightly Misses Estimates Amid Challenging Market Conditions NHPAP Preferred Stock Holds Steady Near Support Amid Quiet Trading MEC Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction ASRT Q1 2026 Earnings Significant EPS Miss Amid Revenue Disclosure Absence SLB Q1 2026 Earnings Marginal EPS Miss Stock Edges Up Amid Mixed Market Signals Reservoir Media RSVR Q1 2026 Earnings A Narrow Beat on the Bottom Line KROS Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Amid Pipeline Progress SKYX Q1 2026 Earnings EPS Falls Short of Estimates Amid Ongoing Development AEON Biopharma Inc AEON Q4 2025 Earnings Significant EPS Miss and Stock Decline Amid Development Challenges